CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Trishula Therapeutics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 23, 2021

Top competitors of Trishula Therapeutics

List of top competitors of Trishula Therapeutics based on patent oppositions.